[ad_1]
A vial of measles, mumps and rubella vaccine (MMR) is photographed at the Community Health Services Clinic in Seattle, Washington, USA on March 20, 2019. Photo taken on March 20, 2019.
(photo credit: REUTERS / LINDSEY WASSON)
X
Dear reader,
As you can imagine, more people are reading the Jerusalem Post than ever before.
Nevertheless, traditional economic models are no longer sustainable and high-quality publications,
like ours, are forced to look for new ways to continue. Unlike many other media outlets,
we have not set up paywall. We want to keep our journalism open
and accessible and be able to continue to provide you with news
and badysis of the front lines of Israel, the Middle East and the Jewish world.
As one of our faithful readers, we ask you to be our partner.
For $ 5 per month, you will have access to the following:
- A user experience almost completely devoid of ads
- Access to our Premium section
- Content of the award-winning Jerusalem Report and our monthly magazine to learn Hebrew – Ivrit
- A brand new electronic paper presenting the daily newspaper as it appears in Israel
Help us grow and continue to tell the story of Israel to the world.
Thank you,
Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief
IMPROVE YOUR JPOST EXPERIENCE BY $ 5 PER MONTH
Show me later
Following the recent measles outbreak in Israel, an expert panel recommended that the Ministry of Health reshape the MMR vaccine delivery methodology to children to "dramatically reduce the risk of infection" in communities around the world. Israel.
The first dose of MMR vaccine is normally given to children aged about one year and the second dose between four and six years. However, the Infectious Diseases Committee explained that advancing the timing of the second dose – and distributing it to children as young as two – would help fight the disease and prevent the next outbreak, Israel Hayom. This recommended methodology will significantly reduce the morbidity and risk of infection in Israeli children aged two to six years.
The experts decided that the first dose should always be given to children from the age of one year, instead of bringing it up to nine months – noting that changing the timing of the second dose would already entail logistical problems "major for Tipot Halav or dispensaries around the country.
The committee's recommendations will likely take several years to implement due to logistical issues, such as the need for additional nurses, a budget, vaccines, and so on. The second dose will also be administered for a few years at the age of two and six years. until the current cycle of immunized children is completed.
The committee decided not to go ahead with two other recommendations, including the notion of increasing the power of the first dose.
The first was to administer the first dose at nine months, then again at one year, and then again in the first year (6 years). In addition, Dr. Arik Haas of the Public Health Services Division of the Ministry of Health said that measles vaccine was also more effective when administered to patients older than one year of age.
The second was to advance the timing of the second dose and give it to children aged 1.5 years. However, experts noted that it may not give children the required time between vaccinations they would need for MMR doses. work properly.
"It was found that children were not getting the vaccine on time and that a significant portion did not receive the first dose until at least 15 months of age. The most important action remains to ensure that the vaccine is administered at the age of 12 months, "said Professor Manfred Green, chairman of the Committee for the Elimination of Measles.
However, a committee member, Dr. Haggay Levine, president of the Association of Public Health Physicians, said that administering an extra dose would deplete current immunization efforts, but would also create confusion in clinics, determining who would have received the right amount. doses and that does not have.
The committee reaffirmed that "the most important action" to prevent measles in young children is to administer the highest possible dose to the first cycle of the MMR vaccine, which will be administered to the child at the One year old. The panel then concluded by explaining the reasoning behind its recommendation to the Ministry of Health, mainly influenced by case studies showing that the morbidity rate in children with measles aged two to six was problematic. , that in most developed countries the vaccine is normally administered before the first degree – as if Israel should do the same.
Join Jerusalem Post Premium Plus now for just $ 5 and enhance your experience with an ad-free website and exclusive content. Click here >>
[ad_2]
Source link
